The impact of immortal time bias on the estimated mortality benefit of antifibrotic therapy in IPF

被引：0

作者：

Wilskow, Marit Bjorna ^{[1
]}

Diep, Phuong Phuong ^{[2
,3
]}

Hyldgaard, Charlotte ^{[4
]}

Carlson, Lisa ^{[5
]}

Kalafatis, Dimitrios ^{[5
]}

Pesonen, Ida ^{[5
]}

Skoeld, Magnus ^{[6
,7
]}

Shaker, Saher Burhan ^{[8
]}

Bendstrup, Elisabeth ^{[9
]}

Hoyer, Nils ^{[8
]}

Durheim, Michael Thomas ^{[2
,3
]}

机构：

[1] Nordland Hosp, Dept Resp Med, Bodo, Norway

[2] Oslo Univ Hosp, Dept Resp Med, Rikshosp, Oslo, Norway

[3] Univ Oslo, Inst Clin Med, Oslo, Norway

[4] Silkeborg Reg Hosp, Diag Ctr, Silkeborg, Denmark

[5] Karolinska Inst, Dept Med Solna, Resp Med Unit, Stockholm, Sweden

[6] Karolinska Univ Hosp, Dept Resp Med & Allergy, Stockholm, Sweden

[7] Karolinska Inst, Dept Med Solna, Stockholm, Sweden

[8] Herlev & Gentofte Hosp, Dept Resp Med, Copenhagen, Denmark

[9] Aarhus Univ, Ctr Rare Lung Dis, Dept Resp Dis & Allergy, Dept Clin Med,Ctr Rare Lung Dis, Aarhus, Denmark

来源：

EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷

关键词：

D O I：

10.1183/13993003.congress-2024.PA2433

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[21] Antifibrotics and mortality in idiopathic pulmonary fibrosis: external validity and avoidance of immortal time bias
Hozumi, Hironao
Miyashita, Koichi
Nakatani, Eiji
Inoue, Yusuke
Yasui, Hideki
Suzuki, Yuzo
Karayama, Masato
Furuhashi, Kazuki
Enomoto, Noriyuki
Fujisawa, Tomoyuki
Inui, Naoki
Suda, Takafumi
RESPIRATORY RESEARCH, 2024, 25 (01)
[22] Vitamin D Use and Mortality in Chronic Kidney Disease: Immortal Time Bias Reply
Kovesdy, Csaba P.
Anderson, John E.
Kalantar-Zadeh, Kamyar
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (21) : 2385 - 2386
[23] Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction
Lai, Tzu-Yu
Hu, Yu-Wen
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (14) : 1623 - +
[24] Survival on antifibrotic therapy in IPF - the impact of pleural plaques, concomitant emphysema and definite vs possible UIP
Anderson, David
Briggs, Sarah
Mckay, Anne
Mccluskey, Susan
Wright, Angela
Chalmers, George
EUROPEAN RESPIRATORY JOURNAL, 2019, 54
[25] Impact of Exposure Definition on Misclassification and Immortal Time Bias in Administrative Claims Databases
Faure, Mareva
Castilloux, Anne-Marie
Lillo-Le-Louet, Agnes
Moride, Yola
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 90 - 91
[26] Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias?
Shin, Ju-Young
Azoulay, Laurent
Filion, Kristian B.
GASTROENTEROLOGY, 2016, 151 (02) : 373 - 373
[27] Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy
Winters, Conchubhair
Ford, Alexander Charles
GUT, 2023, 72 (09) : 1799 - +
[28] Neoadjuvant Therapy in Resectable Pancreatic Cancer: Immortal Time Bias and Its Correction Reply
Mokdad, Ali A.
Minter, Rebecca M.
Zhu, Hong
Mansour, John C.
Choti, Michael A.
Polanco, Patricio M.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (14) : 1624 - +
[29] Statin Use in Patients With Hepatitis C-related Cirrhosis: True Benefit or Immortal Time Bias? Reply
Tate, Janet P.
Mohanty, Arpan
Garcia-Tsao, Guadalupe
GASTROENTEROLOGY, 2016, 151 (02) : 374 - 374
[30] Reply: Immortal time bias in a retrospective study examining colorectal cancer mortality according to adherence to colonoscopy
Zorzi, Manuel
Battagello, Jessica
Amidei, Claudio Barbiellini
GUT, 2023, 72 (11) : 2190 - 2192

← 1 2 3 4 5 →